Fertility Treatment Leader Progyny Breaks Out Past Buy Point As Earnings Surge 113%
· investors.com · popularity 20/100 · 0 similar stories today · Pregnancy & Babies (Lifestyle & Culture)
Read the original at investors.com →
Summary
Fertility treatment leader Progyny (PGNY) surged past a buy point in heavy volume last week after the company's strong third-quarter results. …
Found in: Stocks. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 5.